Trends in Psychiatry and Psychotherapy
https://trends.org.br/journal/trends/article/doi/10.1590/2237-6089-2018-0060
Trends in Psychiatry and Psychotherapy
Original Article

Evaluation of BDNF levels in patients hospitalized for physical trauma at an emergency hospital in Porto Alegre, southern Brazil

Avaliação dos níveis de BDNF em pacientes hospitalizados por trauma físico em um hospital de emergência de Porto Alegre, sul do Brasil

Cleonice Zatti; Luciano Santos Pinto Guimarães; Márcia Rosane Moreira Santana; Eliana Ferreira Gonçalves Scherner; Emílio Salle; Renato Piltcher; Mariana Lunardi Spader; Vitor Crestani Calegaro; Bianca Wollenhaupt-Aguiar; Lúcia Helena Machado Freitas

Downloads: 0
Views: 376

Abstract

Abstract Objective To assess the association between brain-derived neurotrophic factor (BDNF) levels and acute stress disorder (ASD) in patients who have suffered physical trauma. Methods Data were collected at an emergency hospital in Porto Alegre, state of Rio Grande do Sul, southern Brazil. Participants were over 18 years of age, victims of physical trauma, and had been hospitalized for a minimum of 48 hours. A total of 117 hospitalized patients who agreed to participate in the research were grouped according to the shift in which blood was collected (38 subjects from the morning shift and 79 from the afternoon shift), had their BDNF levels measured and responded to other questionnaires. Respondents were further grouped by age into three ranges: 18-30, 31-50 and 51-70 years. Results We found a significant difference in the distribution of BDNF between the two shifts in which blood samples were collected, with the afternoon group having higher BDNF levels (U = 1906.5, p = 0.018). A difference was observed only between the 18-30 group and the 51-70 group in the afternoon shift (Umorning = 1107, pmorning = 0.575; Uafternoon = 7175, pafternoon = 0.028). Conclusions The population whose blood samples were collected in the afternoon showed significantly higher values of BDNF compared to those of the morning shift. This same population presented lower BDNF levels when associated with ASD subtypes A1, A2, and A. We hypothesize that the lower values of BDNF measured in the morning shift were due to a response to the circadian cycle of cortisol, whose action inhibits the expression of serum neurotrophins.

Keywords

Acute stress disorder, BDNF, physical trauma, trauma in childhood

Resumo

Resumo Objetivo Verificar a associação entre os níveis de fator neurotrófico derivado do cérebro (brain-derived neurotrophic factor [BDNF]) e transtorno de estresse agudo (TEA) em pacientes que sofreram trauma físico. Métodos Os dados foram coletados em um hospital de emergência de Porto Alegre, Rio Grande do Sul, Brasil. Os participantes eram maiores de 18 anos, vítimas de trauma físico e estavam hospitalizados por um período mínimo de 48 horas. Um total de 117 pacientes hospitalizados que concordaram em participar da pesquisa foram agrupados de acordo com o turno de realização da coleta de sangue (38 sujeitos no turno da manhã e 79 sujeitos no turno da tarde), tiveram seus níveis de BDNF medidos e responderam a outros questionários. Os entrevistados também foram agrupados por idade em três faixas etárias: 18-30, 31-50 e 51-70 anos. Resultados Encontramos uma diferença significativa na distribuição de BDNF entre os turnos, sendo que o grupo da tarde apresentou níveis maiores de BDNF (U = 1906,5, p = 0,018). Houve diferença entre o grupo de 18-30 anos e o de 51-70 anos no turno da tarde (Umanhã = 1107, pmanhã = 0,575; Utarde = 7175, ptarde = 0,028). Conclusões A população cuja coleta ocorreu à tarde apresentou valores significativamente maiores de BDNF em relação à coleta do turno da manhã. Esta mesma população apresentou menores níveis dessa neurotrofina quando associada com os subtipos A1, A2 e A de TEA. É possível hipotetizar que os menores valores de BDNF aferidos na coleta do turno da manhã se devam a uma resposta ao ciclo circadiano do cortisol, cuja ação inibe a expressão de neurotrofinas séricas.

Palavras-chave

Transtorno de estresse agudo, BDNF, trauma físico, trauma na infância

References

Bryant RA, Creamer M, O’Donnell M, Forbes D, McFarlane AC, Silove D. Acute and chronic posttraumatic stress symptoms in the emergence of posttraumatic stress disorder: a network analysis. JAMA Psychiatry. 2017;74:135-42.

Manual diagnóstico e estatístico de transtornos mentais. 2014.

Breslau N, Chilcoat HD, Kessler RC, Peterson EL, Lucia VC. Vulnerability to assaultive violence: further specification of the sex difference in post-traumatic stress disorder. Psychol Med. 1999;29:813-21.

Birmes P, Brunet A, Carreras D, Ducassé JL, Charlet JP, Lauque D. The predictive power of peritraumatic dissociation and acute stress symptoms for posttraumatic stress symptoms: a three-month prospective study. Am J Psychiatry. 2003;160:1337-9.

Ballenger JC, Davidson JRT, Lecrubier Y, Nutt DJ, Marshall RD. Consensus statement update on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 2004;65:55-62.

Breslau N. Epidemiologic studies of trauma, posttraumatic stress disorder, and other psychiatric disorders. Can J Psychiatry. 2002;47:923-9.

Jones C, Harvey AG, Brewin CR. The organization and content of trauma memories in survival of road traffic accidents. Behav Res Ther. 2007;45:151-62.

Huang EJ, Reichardt LF. Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem. 2013;72:609-42.

Bond M, Gardner S, Christian J, Sigal J. Empirical study of self-rated defense styles. Arch Gen Psychiatry. 1983;40:333-8.

Vaillant GE, Bond M, Vaillant CO. An empirically validated hierarchy of defense mechanisms. Arch Gen Psychiatry. 1986;43:786-94.

Andrews G, Singh M, Bond M. The Defense Style Questionnaire. J Nerv Ment Dis. 1993;181:246-56.

Blaya C, Kipper L, Heldt E, Isolan L, Ceitlin LH, Bondb M. Versão em português do Defense Style Questionaire (DSQ-40) para avaliação dos mecanismos de defesa: um estudo preliminar. Braz J Psychiatry. 2004;26:255-8.

Grassi-Oliveira R, Stein LM, Pezzi JC. Tradução e validação de conteúdo da versão em português do Childhood Trauma Questionnaire. Rev Saude Publica. 2006;40:249-55.

Martins-Monteverde CMS, Padovan T, Juruena MF. Transtornos relacionados a traumas e a estressores. Medicina. 2017;50(^sSupl.1):37-50.

Chen ZY, Patel PD, Sant G, Meng CX, Teng KK, Hempstead BL. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci. 2004;24:4401-11.

Lewin GR, Barde YA. Physiology of the neurotrophins. Annu Rev Neurosci. 1990;19:289-317.

McEwen C, Chattarji S. Molecular mechanisms of neuroplasticity and pharmacological implications: the example of tianeptine. Eur Neuropsychopharmacol. 2004;14:497-502.

Heinrichs M, Wagner D, Schoch W, Soravia LM, Hellhammer DH, Ehlert U. Predicting posttraumatic stress symptoms from pretraumatic risk factors: a 2-year prospective follow-up study in firefighters. Am J Psychiatry. 2005;162:2276-86.

Chen H, Lombés M, Le Menuet D. Glucocoticoid receptor represses brain-derived neurotrophic factor expression in neuron-like cells. Mol Brain. 2017;10.

Gines S, Seong IS, Fossale E, Ivanova E, Trettel F, Gusella JF. Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington’s disease knock-in mice. Hum Mol Genet. 2013;12:497-508.

Counts SE, Mufson EJ. Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity. J Neurochem. 2010;113:649-60.

Dretsch MN, Williams K, Emmerich T, Crynen G, Ait-Ghezala G, Chaytow H. Brain-derived neurotropic factor polymorphisms, traumatic stress, mild traumatic brain injury, and combat exposure contribute to postdeployment traumatic stress. Brain Behav. 2016;6.

Valente NLM, Vallada H, Cordeiro Q, Miguita K, Bressan RA, Andreoli SB. Candidate-gene approach in posttraumatic stress disorder after urban violence: association analysis of the genes encoding serotonin transporter, dopamine transporter, and BDNF. J Mol Neurosci. 2011;44:59-67.

Pivac N, Kozaric-Kovacic D, Grubisic-Ilic M, Nedic G, Rakos I, Nikolac M. The association between brain-derived neurotrophic factor Val66Met variants and psychotic symptoms in posttraumatic stress disorder. World J Biol Psychiatry. 2012;13:306-11.

Bonne O, Gill JM, Luckenbaugh DA, Collins C, Owens MJ, Alesci S. Corticotropin-releasing factor, interleukin-6, brain-derived neurotrophic factor, insulin-like growth factor-1, and substance P in the cerebrospinal fluid of civilians with posttraumatic stress disorder before and after treatment with paroxetine. J Clin Psychiatry. 2011;72:1124-8.

Angelucci F, Ricci V, Gelfo F, Martinotti G, Brunetti M, Sepede G. BDNF serum levels in subjects developing or not post-traumatic stress disorder after trauma exposure. Brain Cogn. 2014;84:118-22.

Hacioglu G, Senturk A, Ince I, Alver A. Assessment of oxidative stress parameters of brain-derived neurotrophic factor heterozygous mice in acute stress model. Iran J Basic Med Sci. 2016;19:388-93.

Hageman I, Andersen HS, Jorgensen MB. Post-traumatic stress disorder: A review of psychobiology and pharmacotherapy. Acta Psychiatr Scand. 2001;104:411-22.

Asevedo E, Gadelha A, Noto C, Mansur RB, Zugman A, Belangero SI. Impact of peripheral levels of chemokines. BDNF and oxidative markers on cognition in individuals with schizophrenia. J Psychiatr Res. 2013;47:1376-82.

Castren E, Rantamaki T. The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Dev Neurobiol. 2010;70:289-97.

Dell’Osso L, Carmassi C, Del Debbio A, Catena Dell’Osso M, Bianchi C, Pozzo E. Brain-derived neurotrophic factor plasma levels in patients suffering from post-traumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:899-902.

Bruenig D, Lurie J, Morris CP, Harvey W, Bruce L, Young RM. Case-control study and meta-analysis reveal BDNF Val66Met is a possible risk factor for PTSD. Neural Plast. 2016;2016.

Andero R, Ressler KJ. Fear extinction and BDNF: translating animal models of PTSD to the clinic. Genes Brain Behav. 2012;11:503-12.

Yang N, Gelaye B, Zhong Q, Rondon MB, Sanchez SE, Williams MA. Serum brain-derived neurotrophic factor (BDNF) concentrations in pregnant women with post-traumatic stress disorder and comorbid depression. Arch Womens Ment Health. 2016;19:979-86.

6165f2eca9539511e809a5a6 trends Articles
Links & Downloads

Trends Psychiatry Psychother

Share this page
Page Sections